Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.14670/HH-18-242

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorShen, Huajuan-
dc.contributor.authorHe, Qiang-
dc.contributor.authorDong, Yongze-
dc.contributor.authorShao, Lina-
dc.contributor.authorLiu, Yueming-
dc.contributor.authorGong, Jianguang-
dc.date.accessioned2022-12-09T11:55:17Z-
dc.date.available2022-12-09T11:55:17Z-
dc.date.issued2020-
dc.identifier.citationHistology and Histopathology Vol. 35, nº10 (2020)es
dc.identifier.issn0213-3911-
dc.identifier.issn1699-5848-
dc.identifier.urihttp://hdl.handle.net/10201/126305-
dc.description.abstractBackground. Chronic kidney disease (CKD) has become a major public health issue, which can lead to renal fibrosis regardless of the initial injury. It has been previously reported that miRNA-1228-3p was correlate with the progression of kidney fibrosis. However, the mechanism by which miRNA-1228-3p regulates renal fibrosis remains unclear. Methods. Renal tubular epithelial cells (HK-2) were treated with TGF-β1 (10 ng/ml) in an in vitro model of renal fibrosis. Gene and protein expressions in HK-2 cells were measured by Western-blot and RT-qPCR, respectively. The relation between miRNA-1228-3p and its target gene was investigated by dual luciferase report analysis. Results. Upregulation of miRNA-1228-3p significantly inhibited TGF-β1-induced fibrosis of HK-2 cells in vitro by targeting GDF11. In addition, miRNA-1228-3p exhibited anti-fibrosis effect through inhibition of the smad2/smad4 signaling pathway. Conclusion. Upregulation of miRNA-1228-3p markedly inhibited the progression of renal fibrosis in vitro, indicating that miRNA-1228-3p may serve as a potential novel target for the treatment of renal fibrosises
dc.formatapplication/pdfes
dc.format.extent9es
dc.languageenges
dc.publisherUniversidad de Murcia, Departamento de Biologia Celular e Histiologiaes
dc.relationSin financiación externa a la Universidades
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectmiRNA-1228-3pes
dc.subjectRenal fibrosises
dc.subjectTGF-β1 signaling pathwayes
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncologíaes
dc.titleUpregulation of miRNA-1228-3p alleviates TGF-β-induced fibrosis in renal tubular epithelial cellses
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doihttps://doi.org/10.14670/HH-18-242-
Aparece en las colecciones:Vol.35,nº10 (2020)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Shen-35-1125-1133-2020.pdf13,98 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons